Literature DB >> 27168952

Analysis of subsets of B cells, Breg, CD4Treg and CD8Treg cells in adult patients with primary selective IgM deficiency.

Ankmalika Gupta Louis1, Sudhanshu Agrawal1, Sudhir Gupta1.   

Abstract

Primary selective IgM deficiency (SIGMD) is a rare and recently IUIS-recognized primary immunodeficiency disease with increased susceptibility to infections, allergy, and autoimmune diseases. The pathogenesis of selective IgM remains unclear. The objective of the study was to understand the pathogenesis of selective IgM deficiency via a comprehensive analysis of subsets of B cells, naïve and memory subsets of CD4+ and CD8+ T cells, and Breg, CD4Treg, and CD8Treg cells. Twenty adult patients with SIGMD (serum IgM 4 mg/dl-32 mg/dl) and age-and gender-matched healthy controls were studied. Naïve B cells, transitional B cells, marginal zone B cells, germinal center B cells, IgM memory B cells, switched memory B cells, plasmablasts, CD21(low) B cells, B1 cells, CXCR3+ naive and memory B cells; naïve, central memory, and effector memory subsets of CD4+ and CD8+ T cells, and CD4Treg, CD8Treg and Breg were phenotypically analyzed using multicolor flow cytometry. A significant increase in CD21(low), IgM memory B cells, Breg and CD8Treg, and a significant decreased in germinal center B cells, and CXCR3+ naïve and memory B cells were observed in SIGMD. These alterations in subsets of B cells, and Breg and CD8Treg cells may play a role in the pathogenesis of SIGMD.

Entities:  

Keywords:  B1 cells; Breg; CD21lo; CD4Treg; CD8Treg; CXCR3+ B cells; germinal center B cells; marginal zone B cells; memory B cells; memory T cells; transitional B cells

Year:  2016        PMID: 27168952      PMCID: PMC4858603     

Source DB:  PubMed          Journal:  Am J Clin Exp Immunol


  76 in total

Review 1.  Characterization of naïve, memory and effector CD8+ T cells: effect of age.

Authors:  Sudhir Gupta; Ruifen Bi; Kevin Su; Leman Yel; Sujata Chiplunkar; Sastry Gollapudi
Journal:  Exp Gerontol       Date:  2004-04       Impact factor: 4.032

Review 2.  B-1 B cell development in the fetus and adult.

Authors:  Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

Review 3.  A case for regulatory B cells.

Authors:  Atsushi Mizoguchi; Atul K Bhan
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

4.  HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes.

Authors:  Hong Jiang; Steve M Canfield; Mary P Gallagher; Hong H Jiang; Yihua Jiang; Zongyu Zheng; Leonard Chess
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

5.  Selective IgM deficiency in adults: phenotypically and functionally altered profiles of peripheral blood lymphocytes.

Authors:  T Ohno; M Inaba; K Kuribayashi; T Masuda; T Kanoh; H Uchino
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

6.  Gamma-M deficiency predisposing to meningococcal septicaemia.

Authors:  J R Hobbs; R D Milner; P J Watt
Journal:  Br Med J       Date:  1967-12-09

7.  The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.

Authors:  Krishanthi S Subramaniam; Kausik Datta; Eric Quintero; Catherine Manix; Matthew S Marks; Liise-Anne Pirofski
Journal:  J Immunol       Date:  2010-04-19       Impact factor: 5.422

8.  CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.

Authors:  Fabian Flores-Borja; Anneleen Bosma; Dorothy Ng; Venkat Reddy; Michael R Ehrenstein; David A Isenberg; Claudia Mauri
Journal:  Sci Transl Med       Date:  2013-02-20       Impact factor: 17.956

Review 9.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

Review 10.  Comparison of diagnostic criteria for common variable immunodeficiency disorder.

Authors:  Rohan Ameratunga; Maia Brewerton; Charlotte Slade; Anthony Jordan; David Gillis; Richard Steele; Wikke Koopmans; See-Tarn Woon
Journal:  Front Immunol       Date:  2014-09-15       Impact factor: 7.561

View more
  11 in total

Review 1.  Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature.

Authors:  Zita Chovancova; Pavlina Kralickova; Alena Pejchalova; Marketa Bloomfield; Jana Nechvatalova; Marcela Vlkova; Jiri Litzman
Journal:  J Clin Immunol       Date:  2017-07-21       Impact factor: 8.317

2.  Defining Primary Selective IgM Deficiency.

Authors:  Sudhir Gupta; Ankmalika Gupta
Journal:  J Clin Immunol       Date:  2019-05-09       Impact factor: 8.317

3.  Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiency.

Authors:  Corrado Campochiaro; Sirin Atay; Kristina E N Clark; Voon Ong; Christopher P Denton
Journal:  BMJ Case Rep       Date:  2019-01-03

Review 4.  Natural IgM and the Development of B Cell-Mediated Autoimmune Diseases.

Authors:  Trang T T Nguyen; Nicole Baumgarth
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

5.  IgAλ monoclonal gammopathy of undetermined significance (MGUS) associated with primary selective IgM deficiency.

Authors:  Sudhir Gupta; Sudhanshu Agrawal
Journal:  Am J Clin Exp Immunol       Date:  2019-08-15

Review 6.  Truly selective primary IgM deficiency is probably very rare.

Authors:  L M A Janssen; T Macken; M C W Creemers; J F M Pruijt; J J J Eijk; E de Vries
Journal:  Clin Exp Immunol       Date:  2017-10-27       Impact factor: 4.330

Review 7.  Selective IgM Deficiency-An Underestimated Primary Immunodeficiency.

Authors:  Sudhir Gupta; Ankmalika Gupta
Journal:  Front Immunol       Date:  2017-09-05       Impact factor: 7.561

8.  Phenotypical T Cell Differentiation Analysis: A Diagnostic and Predictive Tool in the Study of Primary Immunodeficiencies.

Authors:  Enrico Attardi; Silvia Di Cesare; Donato Amodio; Carmela Giancotta; Nicola Cotugno; Cristina Cifaldi; Maria Chiriaco; Paolo Palma; Andrea Finocchi; Gigliola Di Matteo; Paolo Rossi; Caterina Cancrini
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

9.  Challenges in investigating patients with isolated decreased serum IgM: The SIMcal study.

Authors:  Lisanne M A Janssen; Roeland W N M van Hout; Esther de Vries
Journal:  Scand J Immunol       Date:  2019-04-25       Impact factor: 3.487

Review 10.  Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co-infection.

Authors:  Samuel Okurut; David R Boulware; Joseph Olobo; David B Meya
Journal:  Mycoses       Date:  2020-06-19       Impact factor: 4.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.